Aspirin is being trialled as a potential breakthrough treatment for aggressive breast cancer euronews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euronews.com Daily Mail and Mail on Sunday newspapers.
The Scottish Medicines Consortium recommends Merck & Pfizer s Bavencio® (avelumab) as Monotherapy for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma (Bladder Cancer) pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
New Drug Targets Treatment-Resistant Prostate Cancers and Prolongs Trial Participants Lives technologynetworks.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technologynetworks.com Daily Mail and Mail on Sunday newspapers.
E-Mail
A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumour cells, is well tolerated by patients and keeps them alive for longer than standard care, found a phase 3 trial to be presented at the European Association of Urology congress, EAU21, today.
Despite progress in medicine in recent years, metastatic castration-resistant prostate cancer remains untreatable and fatal. The new treatment, known as Lu-PSMA-617, takes a new approach, targeting a molecule called PSMA, which is known to be increased on the surfaces of the tumour cells, destroying them and their surrounding microenvironment.